These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 16580469)
1. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. Orange JS; Hossny EM; Weiler CR; Ballow M; Berger M; Bonilla FA; Buckley R; Chinen J; El-Gamal Y; Mazer BD; Nelson RP; Patel DD; Secord E; Sorensen RU; Wasserman RL; Cunningham-Rundles C; J Allergy Clin Immunol; 2006 Apr; 117(4 Suppl):S525-53. PubMed ID: 16580469 [TBL] [Abstract][Full Text] [Related]
2. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology. Yong PL; Boyle J; Ballow M; Boyle M; Berger M; Bleesing J; Bonilla FA; Chinen J; Cunninghamm-Rundles C; Fuleihan R; Nelson L; Wasserman RL; Williams KC; Orange JS Clin Immunol; 2010 May; 135(2):255-63. PubMed ID: 19914873 [TBL] [Abstract][Full Text] [Related]
3. Update on the use of immunoglobulin in human disease: A review of evidence. Perez EE; Orange JS; Bonilla F; Chinen J; Chinn IK; Dorsey M; El-Gamal Y; Harville TO; Hossny E; Mazer B; Nelson R; Secord E; Jordan SC; Stiehm ER; Vo AA; Ballow M J Allergy Clin Immunol; 2017 Mar; 139(3S):S1-S46. PubMed ID: 28041678 [TBL] [Abstract][Full Text] [Related]
4. [New indications for gamma globulins]. Fontán G; García MC; Pascual-Salcedo D; López Trascasa M; Alvarez Doforno R; Ferreira A An Esp Pediatr; 1992 Jun; 36 Suppl 48():135-8. PubMed ID: 1379010 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases. Daoud YJ; Amin KG Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922 [TBL] [Abstract][Full Text] [Related]
7. Use of intravenous immunoglobulin therapy in autoimmune blistering diseases. Ahmed AR Int Immunopharmacol; 2006 Apr; 6(4):557-78. PubMed ID: 16504919 [TBL] [Abstract][Full Text] [Related]
8. Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation. Wright SE; Shaikh ZH; Castillo-Lugo JA; Tanriover B Transpl Infect Dis; 2008 Jul; 10(4):294-7. PubMed ID: 18086279 [TBL] [Abstract][Full Text] [Related]
15. The product: All intravenous immunoglobulins are not equivalent. Siegel J Pharmacotherapy; 2005 Nov; 25(11 Pt 2):78S-84S. PubMed ID: 16229678 [TBL] [Abstract][Full Text] [Related]
16. History of immunoglobulin replacement. Eibl MM Immunol Allergy Clin North Am; 2008 Nov; 28(4):737-64, viii. PubMed ID: 18940572 [TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms. Bayry J; Dasgupta S; Misra N; Ephrem A; Duong Van Huyen JP; Delignat S; Hassan G; Caligiuri G; Nicoletti A; Lacroix-Desmazes S; Kazatchkine MD; Kaveri S Int Immunopharmacol; 2006 Apr; 6(4):528-34. PubMed ID: 16504915 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in the pathophysiology of primary immune deficiencies and immunoglobulin therapy in HIV infection and autoimmune/inflammatory neurological disorders. Symposium proceedings. Indian Wells, California, January 24-25, 1992. Pediatr Res; 1993 Jan; 33(1 Suppl):S1-100. PubMed ID: 8094549 [No Abstract] [Full Text] [Related]
19. Use of intravenous immunoglobulin G (IVIG). Looney RJ; Huggins J Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538 [TBL] [Abstract][Full Text] [Related]
20. Established and new uses of intravenous immunoglobulin. Cunningham-Rundles C Mt Sinai J Med; 1992 Sep; 59(4):335-40. PubMed ID: 1406751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]